Your session is about to expire
← Back to Search
Vision Training for Healthy Vision(FLAP Trial)
FLAP Trial Summary
This trial looks at how different types of training and therapy can help people with low vision. The findings could help millions of people who suffer from this condition.
- Central Vision Loss
- Age-Related Macular Degeneration
FLAP Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
FLAP Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
FLAP Trial Design
Find a Location
Who is running the clinical trial?
- You are afraid of being in small or enclosed spaces.You have trouble hearing.You have too many or brightly colored tattoos, especially near your head.You have braces or a permanent retainer.You are between 18 and 30 years old.You have a pacemaker or any metal implanted in your body that can be affected by magnets.You need special glasses for seeing far away.Your waist measurement is over 60 inches.You have had a severe head injury in the past.You experience seeing or hearing things that are not real, or strongly believe things that are not true.You have good vision, at least 20/40 or better.You do not have any eye problems.You weigh more than 300 pounds.
- Group 1: Condition 2: Training spatial integration
- Group 2: Condition 3: Training spatial attention
- Group 3: Condition 1: Training visual sensitivity
- Group 4: Condition 4: Combination training
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age restriction for this research limited to those below 70 years old?
"The parameters for entry into this clinical trial require that participants are between 18 and 30 years of age."
Are recruitment efforts ongoing for this clinical experiment?
"Yes, the clinical trial is still ongoing. According to information shared on clinicaltrials.gov this trial was initiated on October 24th 2022 and underwent its latest revision of data on October 31st 2022."
Are there specific criteria for qualifying to join this clinical experiment?
"To join this clinical trial, potential participants must have macular degeneration and be under 30 years of age. Currently, the research team is looking to enrol a cohort of 120 individuals."
What is the overall number of participants in this clinical experiment?
"Affirmative. According to clinicaltrials.gov, this medical experiment is open for recruitment and was initially posted on October 24th 2022 with the latest edit being made on October 31st 2022. The trial necessitates 120 participants from a single research centre."
Share this study with friends